The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Infection with Mycobacterium ulcerans is characterised by tissue necrosis and immunosuppression due to mycolactone, the necessary and sufficient virulence factor for Buruli ulcer disease pathology. Many of its effects are known to involve down-regulation of specific proteins implicated in important cellular processes, such as immune responses and cell adhesion. We have previously shown mycolactone completely blocks the production of LPS-dependent proinflammatory mediators post-transcriptionally. Using polysome profiling we now demonstrate conclusively that mycolactone does not prevent translation of TNF, IL-6 and Cox-2 mRNAs in macrophages. Instead, it inhibits the production of these, along with nearly all other (induced and constitutive) proteins that transit through the ER. This is due to a blockade of protein translocation and subsequent degradation of aberrantly located protein. Several lines of evidence support this transformative explanation of mycolactone function. First, cellular TNF and Cox-2 can be once more detected if the action of the 26S proteasome is inhibited concurrently. Second, restored protein is found in the cytosol, indicating an inability to translocate. Third, in vitro translation assays show mycolactone prevents the translocation of TNF and other proteins into the ER. This is specific as the insertion of tail-anchored proteins into the ER is unaffected showing that the ER remains structurally intact. Fourth, metabolic labelling reveals a near-complete loss of glycosylated and secreted proteins from treated cells, whereas cytosolic proteins are unaffected. Notably, the profound lack of glycosylated and secreted protein production is apparent in a range of different disease-relevant cell types. These studies provide a new mechanism underlying mycolactone's observed pathological activities both in vitro and in vivo. Mycolactone-dependent inhibition of protein translocation into the ER not only explains the deficit of innate cytokines, but also the loss of membrane receptors, adhesion molecules and T-cell cytokines that drive the aetiology of Buruli ulcer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Mycolactone inhibits co-translational translocation of proteins into the ER via a mechanism that does not disrupt the structural integrity of the ER. A–E. In vitro translation (IVT) reactions of different capped transcripts were performed as described +/− mycolactone (MYC; 200 ng/ml unless indicated otherwise), Eeyarestatin 1 (ES1; 250 µM) or DMSO (-; 0.02%). Data representative of 3 independent experiments. A. IVT of luciferase and TNF mRNAs detected by 35S incorporation and Western blot (∼26 kDa) respectively. B. IVT of TNF mRNA was performed in the presence of semi-permeabilised RAW264.7 cells then incubated with no addition (-), or Proteinase K (PK) +/−0.1% Triton-x-100 (PKT) for 1 hr at 4°C before stopping the reaction. C. Dose dependence of loss of the PK protected band. Signal intensity was quantified by ImageJ analysis of non-saturated blots and the protected band (PK) was normalised to total pro-TNF (-). D. IVT of prepro-α Factor (PPAF) and β-lactamase (LACTB) mRNAs in the absence or presence of canine pancreatic microsomal membranes (CPMM). Black arrowhead, glycosylated forms of α Factor; *, signal peptide-cleaved LACTB. E. IVT of PPAF, Sec61β and cytochrome B5 (Cyt-B5) mRNAs in the presence CPMM. After labelling with 35S as described, membranes were isolated by centrifugation through a sucrose cushion [31]. Endoglycosidase H (EndoH) is used to confirm glycosylation of proteins (black arrowhead), the thin line represents where an empty lane was removed from the image for ease of interpretation. F. RAW264.7 cells were incubated +/−125 ng/ml mycolactone (MYC), washed and incubated without mycolactone for various periods (recovery time) before stimulating with LPS for 4 hrs. Supernatant TNF levels were measured by ELISA (mean±SEM of triplicate assays).](https://figures.cochat.ai/paper-figures/08c037fe166d42d5b63952ca096a48fd/the-pathogenic-mechanism-of-the-mycobacterium-ulcerans-virulence-factor-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, inhibiting the 29S proteasome showed that non-glycosylated TNF accumulates in the cytoplasm of mycolactone-treated macrophages, indicating that this causes the failure in TNF secretion.”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These findings were made more general by showing that – in many cell types – mycolactone was inhibiting the translocation of several secreted and membrane proteins into the ER.”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, Hall et al. found that mycolactone does not cause gross changes in translation, with proinflammatory mRNAs being actively translated (102).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, mycolactone blocked the release of several cytokines, chemokines, and other inflammatory mediators from LPS-activated macrophages (102).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
The cited source says what the claim attributes to it.
In the citing paper
“These effects were found not to be due to mycolactone disrupting ER membrane integrity or due to induction of ER-associated degradation pathways.”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [102]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Powley, I. R., Kondrashov, A., Young, L. A., Dobbyn, H. C., Hill, K., Cannell, I. G., Stoneley, M., Kong, Y.-W., Cotes, J. A., Smith, G. C. M., et al. (2009) · Genes & Development · doi:10.1101/gad.516509 · Cited by 150
Self-citationRetractedIngolia, N. T., Lareau, L. F., & Weissman, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.10.002 · Cited by 2,187 · cited 1×
“Puromycin (PURO) causes premature termination and ribosomal release from translating mRNAs, whereas homoharringtonine (HH) prevents translation initiation leading to ribosome run-off of translating mRNAs) [22,23].”
BackgroundX-ray structure of a protein-conducting channel
Berg, B. V. D., Clemons, W. M., Collinson, I., Modis, Y., Hartmann, E., Harrison, S. C., & Rapoport, T. A. (2004) · Nature · doi:10.1038/nature02218 · Cited by 1,250
Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes.
Rapoport, T. A. (2007) · Nature · doi:10.1038/nature06384 · Cited by 977 · cited 1×
“Since TNF and IL-6 are secreted proteins and Cox-2, is ER-resident and contains a signal peptide, their actively-translating, nascent polypeptide chains should be directly associated with the ER due to the interaction of the signal peptide with the signal recognition particle (SRP) and Sec61 complex [24].”
BackgroundInflammasome activation and IL-1β and IL-18 processing during infection
van de Veerdonk, F. L., Netea, M. G., Dinarello, C. A., & Joosten, L. A. B. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.003 · Cited by 691 · cited 1×
“and are secreted by an unconventional mechanism following cleavage of the cytosolic pro-isoforms in a caspase- and inflammasome-dependent manner [40].”
Background[6] Preparation of microsomal membranes for cotranslational protein translocation
Walter, P., & Blobel, G. (1983) · Methods in Enzymology · doi:10.1016/s0076-6879(83)96010-x · Cited by 663 · cited 1×
“Where used, canine microsomal membrane (CPMM) preparations (Promega, or prepared in house [58]; a kind gift of Prof Barnhard Dobberstein [University of Heidelberg]) or semi-permeabilised RAW264.”
MethodMycolactone: A Polyketide Toxin from Mycobacterium ulcerans Required for Virulence
George, K. M., Chatterjee, D., Gunawardana, G., Welty, D., Hayman, J., Lee, R., & Small, P. L. C. (1999) · Science · doi:10.1126/science.283.5403.854 · Cited by 641 · cited 2×
“For instance, the delay between injection of even 100 mg of mycolactone into guinea pig and ulcer formation is 5 days [1], although some early signs of apoptosis are evident from 2 days [7].”
BackgroundP2X7 Receptor Differentially Couples to Distinct Release Pathways for IL-1β in Mouse Macrophage
Pelegrin, P., Barroso-Gutierrez, C., & Surprenant, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7147 · Cited by 410 · cited 1×
“S3C) as they lack the required ASC (Apoptotic speck protein containing a caspase recruitment domain [41]), and so they were not studied further here.”
BackgroundWASP: a key immunological multitasker
Thrasher, A. J., & Burns, S. O. (2010) · Nature Reviews Immunology · doi:10.1038/nri2724 · Cited by 406 · cited 1×
“Mutations in human WASP are associated with a range of immune dysfunction disorders and WASP has also been implicated in Golgi to ER transport [45,46].”
BackgroundGiant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans
Stinear, T. P., Mve-Obiang, A., Small, P. L. C., Frigui, W., Pryor, M. J., Brosch, R., Jenkin, G. A., Johnson, P. D. R., Davies, J. K., Lee, R. E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305877101 · Cited by 389 · cited 1×
“immune responses [1,3].”
Cited by
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Arango Duque, G., & Descoteaux, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00491 · Cited by 2,708
“Importantly, mycolactone blocked the release of several cytokines, chemokines, and other inflammatory mediators from LPS-activated macrophages (102).”
BackgroundMethodInfluentialGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Current Concepts of Antigen Cross-Presentation
Embgenbroich, M., & Burgdorf, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01643 · Cited by 397
“It is generally assumed that members of the ER-associated degradation (ERAD) machinery contribute in enabling antigen dislocation for cross-presentation.”
BackgroundInfluentialCutaneous Mycobacterial Infections
Franco-Paredes, C., Marcos, L. A., Henao-Martínez, A. F., Rodríguez-Morales, A. J., Villamil-Gómez, W. E., Gotuzzo, E., & Bonifaz, A. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-18 · Cited by 289
“ulcerans causes tissue destruction (111, 113), local immunosuppression through the inhibition of protein translocation into the endoplasmic reticulum of cytokines of the innate immune system, membrane receptors, adhesion molecules, and T-cell-dependent cytokines (114).”
BackgroundZika virus induces massive cytoplasmic vacuolization and paraptosis‐like death in infected cells
Monel, B., Compton, A. A., Bruel, T., Amraoui, S., Burlaud‐Gaillard, J., Roy, N., Guivel‐Benhassine, F., Porrot, F., Génin, P., Meertens, L., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695597 · Cited by 164
“…blocks the biogenesis of secretory and integral membrane proteins by inhibiting the Sec61 translocon, the channel guiding nascent polypeptides into the ER lumen (Hall et al , 2014; Guenin-Mace et al , 2015; Kalies & Romisch, 2015; Baron et al , 2016; McKenna et al , 2016; Ravindran et al , 2016).”
An Update on Sec61 Channel Functions, Mechanisms, and Related Diseases
Lang, S., Pfeffer, S., Lee, P.-H., Cavalié, A., Helms, V., Förster, F., & Zimmermann, R. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00887 · Cited by 159
“…A and mycolactone were characterized as Sec61 effectors and shown to have selective (mycolactone) or non-selective (apratoxin A) effects on ER protein import by interaction with the channel (Liu et al., 2009; Hall et al., 2014; Baron et al., 2016; McKenna et al., 2016, 2017; Paatero et al., 2016).”
BackgroundMycolactone subverts immunity by selectively blocking the Sec61 translocon
Baron, L., Paatero, A. O., Morel, J.-D., Impens, F., Guenin-Macé, L., Saint-Auret, S., Blanchard, N., Dillmann, R., Niang, F., Pellegrini, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160662 · Cited by 128
“Hall et al. (2014) showed that mycolactone blocks the translocation of inflammatory mediators (TNF and Cox2) as well as model secretory proteins into the ER, with subsequent degradation of these proteins by the ubiquitin–proteasome system.”
BackgroundInfluentialINS-gene mutations: From genetics and beta cell biology to clinical disease
Liu, M. R., Sun, J., Cui, J., Chen, W., Guo, H., Barbetti, F., & Arvan, P. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.001 · Cited by 133
“Similar to the findings noted above for preproinsulin-R6C, studies of other proteins have shown that blocking SRP-dependent protein translocation induces the expression of heat shock responses, attenuates cell growth, and promotes cell death (Hall et al., 2014; Mutka and Walter, 2001).”
ResultApratoxin Kills Cells by Direct Blockade of the Sec61 Protein Translocation Channel
Paatero, A., Kellosalo, J., Dunyak, B. M., Almaliti, J., Gestwicki, J. E., Gerwick, W. H., Taunton, J., & Paavilainen, V. O. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.04.008 · Cited by 126
Bacterial Toxins as Pathogen Weapons Against Phagocytes
do Vale, A., Cabanes, D., & Sousa, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00042 · Cited by 138
“It has been proposed that this suppression is associated with a mycolactone-induced blockade of co-translational protein translocation into the ER and subsequent degradation of the aberrantly located proteins in the cytosol (Hall et al., 2014; Figure 5).”
BackgroundBuruli Ulcer: a Review of the Current Knowledge
Yotsu, R. R., Suzuki, K., Simmonds, R. E., Bedimo, R., Ablordey, A. S., Yeboah‐Manu, D., Phillips, R. O., & Asiedu, K. B. (2018) · Current Tropical Medicine Reports · doi:10.1007/s40475-018-0166-2 · Cited by 130
Self-citationGrotzke, J. E., Kozik, P., Morel, J.-D., Impens, F., Pietrosemoli, N., Cresswell, P., Amigorena, S., & Demangel, C. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705242114 · Cited by 98
“Mycolactone diffuses passively across the plasma membrane to target the pore-forming subunit of the translocon (Sec61α) (13), leading to the proteasomal degradation of newly synthesized Sec61 clients blocked in translocation (17).”
BackgroundMcKenna, M., Simmonds, R. E., & High, S. (2016) · Journal of Cell Science · doi:10.1242/jcs.182352 · Cited by 105
“Interestingly, the production of several chemokines that bear the hallmarks of SSPs is affected in cell culture models (Coutanceau et al., 2007; Hall et al., 2014).”
BackgroundMethodInfluentialSelf-citationSarfo, F. S., Phillips, R. O., Wansbrough-Jones, M. H., & Simmonds, R. E. (2015) · Cellular Microbiology · doi:10.1111/cmi.12547 · Cited by 116
“Cellular Microbiology P while the purpose of this study was to explain the lack of inflammation in BU, the identified mechanism probably impacts the pathogenesis in multiple ways (Hall et al., 2014; Ogbechi et al., 2015).”
BackgroundInfluentialSelf-citationIpomoeassin F Binds Sec61α to Inhibit Protein Translocation
Zong, G., Hu, Z., O’Keefe, S., Tranter, D., Iannotti, M. J., Baron, L., Hall, B., Corfield, K., Paatero, A. O., Henderson, M. J., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13506 · Cited by 93
Self-citationOgbechi, J., Hall, B. S., Sbarrato, T., Taunton, J., Willis, A. E., Wek, R. C., & Simmonds, R. E. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0427-y · Cited by 84
“Polysomes were prepared and RNA purified as described in Hall et al.(4).”
BackgroundMethodSelf-citationBieri, R., Scherr, N., Ruf, M., Dangy, J., Gersbach, P., Gehringer, M., Altmann, K., & Pluschke, G. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00053 · Cited by 89
Protein Transport into the Human Endoplasmic Reticulum
Dudek, J., Pfeffer, S., Lee, P.-H., Jung, M., Cavalié, A., Helms, V., Förster, F. G., & Zimmermann, R. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.06.011 · Cited by 90
Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans
Zingué, D., Bouam, A., Tian, R. B. D., & Drancourt, M. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00045-17 · Cited by 89
Skin and Soft Tissue Infections Due to Nontuberculous Mycobacteria
Misch, E. A., Saddler, C. M., & Davis, J. M. (2018) · Current Infectious Disease Reports · doi:10.1007/s11908-018-0611-3 · Cited by 87
Sec61 blockade by mycolactone: A central mechanism in Buruli ulcer disease
Demangel, C., & High, S. (2018) · Biology of the Cell · doi:10.1111/boc.201800030 · Cited by 81
“Furthermore, non-translocated forms of specific precursor proteins could be stabilised in cell culture models by using proteasome inhibitors [Hall et al., 2014], suggesting that the non-translocated forms of these hydrophobic precursor proteins are normally degraded via cytosolic quality control pathways [Casson et al.”
BackgroundInfluentialSelf-citationProteomics Reveals Scope of Mycolactone-mediated Sec61 Blockade and Distinctive Stress Signature
Morel, J.-D., Paatero, A. O., Wei, J., Yewdell, J. W., Guenin-Macé, L., Van Haver, D., Impens, F., Pietrosemoli, N., Paavilainen, V. O., & Demangel, C. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000824 · Cited by 74
“radation by the ubiquitin-proteasome system (3, 4).”
A common mechanism of Sec61 translocon inhibition by small molecules
Itskanov, S., Wang, L., Junne, T., Sherriff, R., Xiao, L., Blanchard, N., Shi, W. Q., Forsyth, C., Hoepfner, D., Spiess, M., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01337-y · Cited by 77
McKenna, M., Simmonds, R. E., & High, S. (2017) · Journal of Cell Science · doi:10.1242/jcs.198655 · Cited by 73
“, 2015) as a direct result of its effect on the Sec61 complex at the endoplasmic reticulum (ER; Baron et al., 2016; Hall et al., 2014; Ogbechi et al., 2015; McKenna et al., 2016).”
InfluentialSelf-citationCoibamide A Targets Sec61 to Prevent Biogenesis of Secretory and Membrane Proteins
Tranter, D., Paatero, A. O., Kawaguchi, S., Kazemi, S., Serrill, J. D., Kellosalo, J., Vogel, W. K., Richter, U., Mattos, D. R., Wan, X., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00325 · Cited by 67
Mechanism of Protein Translocation by the Sec61 Translocon Complex
Itskanov, S., & Park, E. (2022) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041250 · Cited by 70
Structure of the Inhibited State of the Sec Translocon
Gérard, S. F., Hall, B. S., Zaki, A. M., Corfield, K. A., Mayerhofer, P. U., Costa, C., Whelligan, D. K., Biggin, P. C., Simmonds, R. E., & Higgins, M. K. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.013 · Cited by 60
“Of the current inhibitors, mycolactone (Figure 1A) is the most potent (Hall et al., 2014).”
BackgroundMethodInfluentialSelf-citationOgbechi, J., Ruf, M., Hall, B. S., Bodman-Smith, K. B., Vogel, M., Wu, H.-L., Stainer, A. R., Esmon, C. T., Ahnström, J., Pluschke, G., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005011 · Cited by 63
“However, similarly to Cox-2 and TNF in macrophages [18], TM depletion could be reversed by inhibiting the proteasome (Fig 2D).”
InfluentialSelf-citationShaping mycolactone for therapeutic use against inflammatory disorders
Guenin‐Macé, L., Baron, L., Chany, A., Tresse, C., Saint-Auret, S., Jönsson, F., Chevalier, F. L., Bruhns, P., Bismuth, G., Hidalgo‐Lucas, S., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0458 · Cited by 58
“Although the molecular receptor mediating these effects remains to be identified, there is recent evidence showing that mycolactone operates by an original mechanism of posttranscriptional blockade of protein synthesis, selectively affecting membrane and secreted proteins (17).”
BackgroundSignal Peptide-Binding Drug as a Selective Inhibitor of Co-Translational Protein Translocation
Vermeire, K., Bell, T. W., Van Puyenbroeck, V., Giraut, A., Noppen, S., Liekens, S., Schols, D., Hartmann, E., Kalies, K.-U., & Marsh, M. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1002011 · Cited by 54
“Mycolactone, the virulence factor of Mycobacterium ulcerans has recently been described to block protein translocation into the ER, and thus, to prevent secretion of innate cytokines and expression of important immune-related membrane receptors [57].”
BackgroundNatural products as modulators of eukaryotic protein secretion
Luesch, H., & Paavilainen, V. O. (2020) · Natural Product Reports · doi:10.1039/c9np00066f · Cited by 53
Van Puyenbroeck, V., & Vermeire, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2743-2 · Cited by 50
“showed that mycolactone is a non-selective inhibitor of Sec61-dependent translocation across the ER [29].”
BackgroundFoulon, M., Robbe-Saule, M., Manry, J., Esnault, L., Boucaud, Y., Alcaïs, A., Malloci, M., d’Andon, M. F., Beauvais, T., Labarrière, N., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009107 · Cited by 51
Gama, J. B., Ohlmeier, S., Martins, T. G., Fraga, A. G., Sampaio‐Marques, B., Carvalho, M. A., Proença, M. F. R. P., Silva, M. T., Pedrosa, J., & Ludovico, P. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003066 · Cited by 52
“Even though, the methodology used has some limitations, since it excludes the analysis of transmembrane and secretory proteins, which were found to be severely affected by mycolactone [28], this work is the first proteomic study on the effect of mycolactone on cells, unveiling important information about the toxin act…”
BackgroundMethodThe potent effect of mycolactone on lipid membranes
Nitenberg, M., Bénarouche, A., Maniti, O., Marion, E., Marsollier, L., Géan, J., Dufourc, É. J., Cavalier, J., Canaan, S., & Girard-Egrot, A. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006814 · Cited by 52
“Despite the wealth of research describing the pathogenic mechanism [14,34,37], there is still no molecular explanation of the necrosis seen in the ulcers, over and above cytopathic activity, and the immunomodulatory or analgesic properties of mycolactone [13,24].”
BackgroundSicking, M., Lang, S., Bochen, F., Roos, A., Drenth, J. P. H., Zakaria, M., Zimmermann, R., & Linxweiler, M. (2021) · Cells · doi:10.3390/cells10051036 · Cited by 49
“Mycolcatone from Mycobacterium ulcerans is central to the etiology of Buruli ulcer [242,245].”
BackgroundRahman, M. A., Sobia, P., Dwivedi, V. P., Bhawsar, A., Singh, D. K., Sharma, P., Moodley, P., Kaer, L. V., Bishai, W. R., & Das, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.653600 · Cited by 45
Genetic Variation in Autophagy-Related Genes Influences the Risk and Phenotype of Buruli Ulcer
Capela, C., Dossou, A. D., Silva-Gomes, R., Sopoh, G. E., Makoutodé, M., Menino, J. F., Fraga, A. G., Cunha, C., Carvalho, A., Rodrigues, F. J. S., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004671 · Cited by 44
Kwofie, S. K., Dankwa, B., Enninful, K. S., Adobor, C., Broni, E., Ntiamoah, A., & Wilson, M. D. (2019) · Toxins · doi:10.3390/toxins11030181 · Cited by 44
“Mycobacterium ulcerans is known to produce a lipid-like exotoxin called mycolactone [6].”
BackgroundA Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone
Song, O., Kim, H., Jouny, S., Ricard, I., Vandeputte, A., Deboosère, N., Marion, E., Queval, C. J., Lesport, P., Bourinet, E., et al. (2017) · Toxins · doi:10.3390/toxins9070227 · Cited by 41
“Concomitantly, Simmons and colleagues reported that mycolactone-induced cytotoxicity was caused by the inhibition of Sec61-dependent translocation, leading to profound changes in cellular signaling [29].”
BackgroundThe chemistry and biology of mycolactones
Gehringer, M., & Altmann, K. (2017) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.13.159 · Cited by 42
(2023) · doi:10.1126/sciadv.adf0797 · Cited by 38
“…inhibitors of the Sec61 translocon include co-transin ( 43 ), apratoxin A ( 44 ), coibamide A ( 37 ), ipomoeassin F ( 39 ), mycolactone ( 45 ), and cyclotriazadisulfonamide (CADA) Right: Superposition of the SP-engaged translocon (green/cyan) with the ribosome-primed translocon (gray).”
Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-Morbidities
Llibre, A., Dedicoat, M. J., Burel, J. G., Demangel, C., O’Shea, M. K., & Mauro, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.747387 · Cited by 40
Mycolactone: More than Just a Cytotoxin
Guenin‐Macé, L., Ruf, M., Pluschke, G., & Demangel, C. (2019) · Springer eBooks · doi:10.1007/978-3-030-11114-4_7 · Cited by 41
Signal peptide mimicry primes Sec61 for client-selective inhibition
Rehan, S., Tranter, D., Sharp, P. P., Craven, G. B., Lowe, E., Anderl, J. L., Muchamuel, T., Abrishami, V., Kuivanen, S., Wenzell, N. A., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01326-1 · Cited by 38
“We also directly compared KZR-8445 to mycolactone A/B, a structurally distinct and relatively client-nonselective Sec61 inhibitor 8,23 , for their ability to discriminate between VCAM and preprolactin (pPL) signal peptides.”
McLean, K. J., Leys, D., & Munro, A. W. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_6 · Cited by 39
The Sec61 translocon is a therapeutic vulnerability in multiple myeloma
Domenger, A., Choisy, C., Baron, L., Mayau, V., Perthame, É., Deriano, L., Arnulf, B., Bories, J.-C., Dadaglio, G., & Demangel, C. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202114740 · Cited by 35
Ablordey, A. S., Vandelannoote, K., Aboagye, I. F., Ahortor, E. K., Amissah, N. A., Eddyani, M., Durnez, L., Portaels, F., de Jong, B. C., Leirs, H., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003681 · Cited by 37
The Angiotensin II Type 2 Receptor for Pain Control
Danser, A. H. J., & Anand, P. (2014) · Cell · doi:10.1016/j.cell.2014.05.030 · Cited by 34
“In addition, mycolactonedependent inhibition of protein translocation into the endoplasmic reticulum may also explain the deficit of cytokines (Hall et al., 2014).”
BackgroundBuruli Ulcer: Mycobacterium Ulcerans Disease
Röltgen, K., & Pluschke, G. (2019) · Springer eBooks · doi:10.1007/978-3-030-11114-4 · Cited by 43
Anand, U., Sinisi, M., Fox, M., MacQuillan, A. H. F., Quick, T., Korchev, Y. E., Bountra, C., McCarthy, T. D., & Anand, P. (2016) · Molecular Pain · doi:10.1177/1744806916654144 · Cited by 37
“ML inhibits protein translocation into the endoplasmic reticulum resulting in the deficit of cytokines.(15) Such an effect would explain the lack of inflammation, secretion of inflammatory cytokines, and, thereby, the lack of inflammatory pain sensation.”
BackgroundResultRing Expansion Leads to a More Potent Analogue of Ipomoeassin F
Zong, G., Hu, Z., Duah, K. B., Andrews, L. E., Zhou, J., O’Keefe, S. M., Whisenhunt, L., Shim, J. S., Du, Y., High, S., et al. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c01659 · Cited by 32
Self-citationShort Convergent Synthesis of the Mycolactone Core Through Lithiation–Borylation Homologations
Brown, C. A., & Aggarwal, V. K. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201503122 · Cited by 32
Optimization of Membrane Electrode Assembly of PEM Fuel Cell by Response Surface Method
Vuppala, R. K. S. S., Chaedir, B. A., Jiang, L., Chen, L., Aziz, M., & SASMITO, A. P. (2019) · Molecules · doi:10.3390/molecules24173097 · Cited by 32
Membrane perturbing properties of toxin mycolactone from Mycobacterium ulcerans
López, C. A., Ünkefer, C. J., Swanson, B. I., Swanson, J. M. J., & Gnanakaran, S. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005972 · Cited by 32
“We speculate that such effects could easily translate to a broad number of biochemical signatures typical of the pathogenesis of the Buruli ulcer disease [8,22,24].”
InfluentialSynthetic Variants of Mycolactone Bind and Activate Wiskott–Aldrich Syndrome Proteins
Chany, A., Veyron‐Churlet, R., Tresse, C., Mayau, V., Casarotto, V., Chevalier, F. L., Guenin‐Macé, L., Demangel, C., & Blanchard, N. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008819 · Cited by 30
ATG5 Promotes Death Signaling in Response to the Cyclic Depsipeptides Coibamide A and Apratoxin A
Wan, X., Serrill, J., Humphreys, I., Tan, M. H., McPhail, K. L., Ganley, I. G., & Ishmael, J. E. (2018) · Marine Drugs · doi:10.3390/md16030077 · Cited by 30
“This lack of BiP and CHOP induction in response to coibamide A or apratoxin A, is instead more consistent with the lack of conventional ER stress biomarkers noted after exposure to the Sec61 inhibitor mycolactone [43].”
BackgroundImmunity against Mycobacterium ulcerans: The subversive role of mycolactone
Demangel, C. (2021) · Immunological Reviews · doi:10.1111/imr.12956 · Cited by 29
Systematic review of M. Bovis BCG and other candidate vaccines for Buruli ulcer prophylaxis
Muhi, S., & Stinear, T. P. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.05.092 · Cited by 28
Hall, B. S., Santos, S. J. D., Hsieh, L. T.-H., Manifava, M., Ruf, M., Pluschke, G., Ktistakis, N. T., & Simmonds, R. E. (2021) · Autophagy · doi:10.1080/15548627.2021.1961067 · Cited by 27
“proteasome plays an important part in clearing these proteins [6,7], but our findings suggest that selective autophagy may also be needed to protect the cells from the toxic effects of the”
BackgroundInfluentialSelf-citationMycolactone displays anti-inflammatory effects on the nervous system
Isaac, C., Mauborgne, A., Grimaldi, A., Adé, K., Pohl, M., Limatola, C., Boucher, Y., Demangel, C., & Guenin‐Macé, L. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006058 · Cited by 30
“Mycolactone binding to the pore-forming subunit of the translocon (Sec61α) was shown to cause the proteasomal degradation of all newly synthesized Sec61 clients blocked in translocation [12].”
BackgroundShah, J. A., Berrington, W. R., Vary, J. C., Wells, R. D., Peterson, G. J., Kunwar, C. B., Khadge, S., Hagge, D. A., & Hawn, T. R. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv570 · Cited by 31
“colactone, which inhibits production of cytokine mRNA in macrophages by preventing protein translocation into the endoplasmic reticulum [40, 41].”
BackgroundAdusumilli, S., & Haydel, S. E. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1020-5 · Cited by 23
“into the endoplasmic reticulum, leading to degradation of aberrantly-located proteins [33], so reduction”
BackgroundMycolactone induces cell death by SETD1B-dependent degradation of glutathione
Förster, B., Demangel, C., & Thye, T. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008709 · Cited by 26
“Downstream apoptotic targets of ATF4, such as CHOP and BIM, were previously proposed to mediate mycolactone-induced cell death in other, diploid cell lines [4,5,12].”
BackgroundInhibitors of Protein Translocation Across the ER Membrane
Kalies, K., & Römisch, K. (2015) · Traffic · doi:10.1111/tra.12308 · Cited by 26
“Mycolactone does not suppress transcription or translation of proinflammatory cytokines, but rather their translocation across the ER membrane (65,66).”
BackgroundInfluentialHsieh, L. T.-H., Santos, S. J. D., Hall, B. S., Ogbechi, J., Loglo, A. D., Salguero, F. J., Ruf, M., Pluschke, G., & Simmonds, R. E. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010280 · Cited by 25
“In our model, the direct effect is slow, driven by the cytotoxicity that follows Sec61 inhibition, which takes several days [22], The indirect effect results from fibrin deposition after rapid loss of Sec61-dependent coagulation modulators, causing mycolactone-induced ischaemia.”
BackgroundSelf-citationRöltgen, K., & Pluschke, G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01018 · Cited by 25
Bhadra, P., Santos, S. J. D., Gamayun, I., Pick, T., Neumann, C., Ogbechi, J., Hall, B. S., Zimmermann, R., Helms, V., Simmonds, R. E., et al. (2021) · Biochemical Journal · doi:10.1042/bcj20210345 · Cited by 21
“The experiments were done with a HEK-293 cell line that stably expresses the FRET-based D1ER sensor in the ER lumen (D1ER-HEK) as well as with HCT116 cells that express Sec61 α mutants (D60G, R66K, S71F, S82Y, Q127K) and RAW 264.7 cells [11,15,16,34].”
InfluentialSelf-citationHall, B. S., Hsieh, L. T.-H., Sacre, S. M., & Simmonds, R. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.788146 · Cited by 22
“Crucially, this is the first mechanistic explanation for the biological effects of mycolactone that has been corroborated by multiple labs worldwide (16, 18, 38, 39), and is now accepted by the WHO as the mechanism that substantially explains the immunosuppression and cytotoxicity in BU (40).”
BackgroundInfluentialSelf-citationMangas, K. M., Buultjens, A. H., Porter, J. L., Baines, S. L., Marion, E., Marsollier, L., Tobias, N. J., Pidot, S. J., Quinn, K. M., Price, D. J., et al. (2019) · Infection and Immunity · doi:10.1128/iai.00753-19 · Cited by 22
“However, many studies have shown that mycolactone suppresses TNF- production by T cells and especially macrophages (45, 80), decreasing their ability to control BU infection (81).”
BackgroundSimmonds, R. E. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15065.2 · Cited by 21
Self-citationMycolactone Toxin Membrane Permeation: Atomistic versus Coarse-Grained MARTINI Simulations
Aydin, F., Sun, R., & Swanson, J. M. J. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.05.012 · Cited by 22
Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease
Niang, F., Sarfo, F. S., Frimpong, M., Guenin‐Macé, L., Wansbrough-Jones, M. H., Stinear, T. P., Phillips, R. O., & Demangel, C. (2015) · Scientific Reports · doi:10.1038/srep17693 · Cited by 21
“Although its precise mechanism of action remains to be elucidated, there is recent evidence that mycolactone blocks the co-translational translocation of secreted and membrane-bound proteins into the endoplasmic reticulum 21,22 .”
Sec61 complex/translocon: The role of an atypical ER Ca2+-leak channel in health and disease
Parys, J. B., & Coppenolle, F. V. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.991149 · Cited by 20
Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer
En, J., Kitamoto, S., Kawashima, A., Yonezawa, S., Kishi, Y., Ishii, N., & Goto, M. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005834 · Cited by 23
“Recent studies revealed that mycolactone inhibits the production of inflammatory mediator by blocking the translocation into endoplasmic reticulum [21].”
BackgroundChallenges associated with the treatment of Buruli ulcer
Aboagye, S. Y., Kpeli, G. S., Tuffour, J., & Yeboah‐Manu, D. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-128 · Cited by 18
Pauwels, E., Rutz, C., Provinciael, B., Stroobants, J., Schols, D., Hartmann, E., Krause, E., Stephanowitz, H., Schülein, R., & Vermeire, K. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100144 · Cited by 16
“Other known examples of compounds that interact with the Sec61 translocon but in a substrate nonselective manner are mycolactone (34, 35), aprotoxin A (36, 37), decatransin (38), coibamide A (39, 40), and ipomoeassin F (41).”
BackgroundReceveur, J. P., Bauer, A. J., Pechal, J. L., Picq, S., Dogbe, M., Jordan, H. R., Rakestraw, A. W., Fast, K. M., Sandel, M. J., Chevillon, C., et al. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab045 · Cited by 17
Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters
Babonneau, J., Bréard, D., Reynaert, M., Marion, E., Guilet, D., Saint‐André, J., Croué, A., Brodin, P. M., Richomme, P., & Marsollier, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00378 · Cited by 15
“Mycolactone pathogenicity was shown to be mediated by the blockade of proteins translocation into the endoplasmic reticulum (Hall et al., 2014).”
BackgroundIpomoeassin-F disrupts multiple aspects of secretory protein biogenesis
Roboti, P., O’Keefe, S. M., Duah, K. B., Shi, W. Q., & High, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-91107-4 · Cited by 16
Self-citationPuyenbroeck, V. V., Pauwels, E., Provinciael, B., Bell, T. W., Schols, D., Kalies, K., Hartmann, E., & Vermeire, K. (2019) · Traffic · doi:10.1111/tra.12713 · Cited by 15
Natural antioxidants attenuate mycolactone toxicity to RAW 264.7 macrophages
Kwaffo, Y. A., Duah, M. S., Owusu-Boateng, K., Gbewonyo, W. S. K., Adjimani, J. P., & Mosi, L. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211015628 · Cited by 16
“and Hall et al.(10) have also reported of macrophage sensitivity toML in vitro, occurring at high concentrations and prolonged exposure.”
BackgroundInfluentialFoulon, M., Pouchin, A., Manry, J., Khater, F., Robbe-Saule, M., Durand, A., Esnault, L., Delneste, Y., Jeannin, P., Saint‐André, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aax7781 · Cited by 17
“Mycolactone is known to inhibit the production of inflammatory cytokines by binding to the Sec61 translocon (25).”
BackgroundImmune-evasion Strategies of Mycobacteria and Their Implications for the Protective Immune Response
Fraga, A. G., Barbosa, A. M., Ferreira, C. M., Fevereiro, J., Pedrosa, J., & Torrado, E. (2017) · Current Issues in Molecular Biology · doi:10.21775/cimb.025.169 · Cited by 16
“Another well-known effect of mycolactone is the down-regulation of specific proteins implicated in host immunity, such as cytokines and chemokines (Baron et al., 2016; Hall et al., 2014; Simmonds et al., 2009; Torrado et al., 2007).”
BackgroundInfluentialKwofie, S. K., Enninful, K. S., Yussif, J. A., Asante, L. A., Adjei, M., Kan‐Dapaah, K., Tiburu, E. K., Mensah, W. A., Miller, W. A., Mosi, L., et al. (2019) · Molecules · doi:10.3390/molecules24122299 · Cited by 14
“It has also been shown to have immunosuppressive properties by inhibiting the phagocytic abilities of the phagocytic white blood cells and killing neutrophils dispatched to infected tissues [2,12].”
BackgroundOmansen, T. F., Marcsisin, R. A., Chua, B. Y. L., Zeng, W., Jackson, D. C., Porter, J. L., Stienstra, Y., van der Werf, T. S., & Stinear, T. P. (2019) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.18-0959 · Cited by 14
“The suppression of cytokines is due to the inhibition by ML of the nascent membrane, and secretory proteins egress through the endoplasmic reticulum membrane.(6,62) In human patients with BU, overall suppressed IFN-γ levels are seen.”
BackgroundRobbe-Saule, M., Foulon, M., Poncin, I., Esnault, L., Varet, H., Legendre, R., Besnard, A., Grzegorzewicz, A. E., Jackson, M., Canaan, S., et al. (2021) · Virulence · doi:10.1080/21505594.2021.1929749 · Cited by 13
Hsieh, L. T.-H., Hall, B. S., Newcombe, J., Mendum, T. A., Santana‐Varela, S., Umrania, Y., Deery, M. J., Shi, W. Q., Díaz‐Delgado, J., Salguero, F. J., et al. (2023) · eLife · doi:10.7554/elife.86931 · Cited by 13
Self-citationKlein, W., Rutz, C., Eckhard, J., Provinciael, B., Specker, E., Neuenschwander, M., Kleinau, G., Scheerer, P., von Kries, J. P., Nazaré, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208641 · Cited by 10
Insulin gene mutations and posttranslational and translocation defects: associations with diabetes
Arneth, B. M. (2020) · Endocrine · doi:10.1007/s12020-020-02413-2 · Cited by 10
“In some studies, researchers have focused on PTM defects that are directly related to the development of diabetes [56].”
BackgroundInfluentialKadeřábková, N., Mahmood, A. J. S., Furniss, R. C. D., & Mavridou, D. A. I. (2023) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2023.05.003 · Cited by 12
Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls
Reynaert, M., Dupoiron, D., Yeramian, E., Marsollier, L., & Brodin, P. M. (2019) · Toxins · doi:10.3390/toxins11090516 · Cited by 8
“Sec61 translocon, a heterotrimeric membrane protein complex essential for protein translocation into the ER, was thus identified as a major target of mycolactone [88], and its inhibition by the toxin was shown to have critical consequences on the immune system [61].”
BackgroundYeola, A. P., Akbar, I., Baillargeon, J., Doss, P. M. I. A., Paavilainen, V. O., & Rangachari, M. (2020) · Cytokine · doi:10.1016/j.cyto.2019.154944 · Cited by 9
From Bacterial Toxin to Therapeutic Agent: The Unexpected Fate of Mycolactone
Ricci, D., & Demangel, C. (2023) · Toxins · doi:10.3390/toxins15060369 · Cited by 9
“breakthrough by demonstrating that mycolactone prevents the translocation of model secretory proteins into the endoplasmic reticulum (ER), leading to their degradation in the cytosol by the ubiquitin–proteasome system [15].”
BackgroundMuhi, S., Osowicki, J., O'Brien, D. P., Johnson, P. D. R., Pidot, S. J., Doerflinger, M., Marshall, J. L., Pellegrini, M., McCarthy, J. S., & Stinear, T. P. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011394 · Cited by 8
“By this mechanism, mycolactone irreversibly inhibits the production of numerous cytokines [20], including interleukin-2 (IL-2) [21,22] and interferon gamma (IFN-γ) [23].”
BackgroundThe Immunology of Buruli Ulcer
Fevereiro, J., Fraga, A. G., & Pedrosa, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-11114-4_8 · Cited by 13
Xin, J., Yin, K., Li, S., Gu, P., & Shao, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1580086 · Cited by 7
Naveed, M., Ali, I., Aziz, T. A., Saleem, A., Rajpoot, Z., Khaleel, S., Khan, A. A., Al-harbi, M., & Albekairi, T. H. (2025) · Scientific Reports · doi:10.1038/s41598-024-83908-0 · Cited by 7
Strong, E. J., Hart, B. E., Wang, J., González-Orozco, M., & Lee, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.750643 · Cited by 7
Yotsu, R. R., Simmonds, R. E., de Souza, D. K., Phillips, R. O., Amoako, Y. A., Srivastava, S., Asiedu, K. B., Eyangoh, S. I., Johnson, P. D. R., & Pluschke, G. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00672-9 · Cited by 6
“…secreted cytokines, chemokines and innate immune mediators by monocytes and macrophages, such as TNF, type 1 interferon, IL-6, IL-8, COX2 and others 12,277 • Inhibits phagocytosis 278 • * Inhibits antigen presentation by dendritic cells after prolonged exposure through effects on MHC-I and MHC-II…”
InfluentialSelf-citation
Metadata
- Authors
- Hall, B. S., Hill, K., McKenna, M., Ogbechi, J., High, S., Willis, A. E., & Simmonds, R. E.
- Affiliations
- University of Surrey (GB)
- Babraham Institute (GB)
- University of Manchester (GB)
- Corresponding author
- Simmonds, Rachel E.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-04-03
- Volume
- 10
- Issue
- 4
- Pages
- e1004061
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3974873
- OpenAlex
- W2061277860
- Semantic Scholar
- 5212d6d5ae6ba36ce1c7bcab6a815efbff42e4ad
- Cited by
- 162
- References
- 61
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 6 · 2023: 24 · 2022: 16 · 2021: 14 · 2020: 12 · 2019: 17 · 2018: 15 · 2017: 13 · 2016: 7 · 2015: 12 · 2014: 9
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Harvard University
- Wellcome Trust (WT092744)
- Biotechnology and Biological Sciences Research Council (BB/F02326X/2, 1338405, 1626839)
- Topics
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
- Keywords
- Mycobacterium ulcerans, mycolactone, Buruli ulcer, virulence factors, protein translocation, endoplasmic reticulum, protein degradation, 26S proteasome, TNF-α, interleukin-6, cyclooxygenase-2, macrophages, glycosylated proteins, secreted proteins, immunosuppression, tissue necrosis, post-transcriptional regulation
- MeSH terms
- Animals, Cell Line, Endoplasmic Reticulum, Lipopolysaccharides, Protein Biosynthesis, Tumor Necrosis Factor-alpha, Cell Adhesion Molecules, Interleukin-6, Inflammation Mediators, Macrolides, Mycobacterium ulcerans, Protein Transport, Mice, Cyclooxygenase 2, Buruli Ulcer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.